{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:57:18Z","timestamp":1794412638780,"version":"4.9.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Oulu including Oulu University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To evaluate the impact of cholangitis on survival of patients with gastrointestinal cancer and malignant biliary obstruction treated with percutaneous transhepatic biliary drainage (PTBD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective registry study was performed at a tertiary center from 2000 to 2016 in Northern Finland.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study included 588 patients, 258 (43.9%) patients with pancreatic cancer, 222 (37.7%) with biliary tract cancer, and 108 (18.4%) with metastasis from gastrointestinal cancers. Patient mean age was 70 years, range 26\u2009\u2212\u200993 years. There were 288 [49.0%] women. The 30-day mortality rate was 30.8% for 156 patients with cholangitis before PTBD, 19.5% for 215 patients with cholangitis after PTBD and 25.8% for 217 patients without cholangitis (<jats:italic>P<\/jats:italic>\u2009=\u20090.039). The median survival was 1.8 months for patients with cholangitis before PTBD, 3.0 months for patients with cholangitis after PTBD, and 3.2 months for patients without cholangitis (<jats:italic>P<\/jats:italic>\u2009=\u20090.002). The hazard ratio (HR) for 1-year mortality for patients with cholangitis before PTBD was 1.3 (95% CI 1.06\u2009\u2212\u20091.67, <jats:italic>P<\/jats:italic>\u2009=\u20090.015) compared to patients with cholangitis after PTBD. After successful PTBD, 54 out of 291 patients received chemotherapy; the median survival was 5.2 months with cholangitis before PTBD, 9.4 months with cholangitis after PTBD and 15.3 months without cholangitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In gastrointestinal cancers with malignant biliary obstruction, survival is poorer if cholangitis occurs before PTBD compared to cholangitis after PTBD. An oncologist\u2019s consultation is essential for assessing the possibility of chemotherapy in successfully treated PTBD patients, because of the notable survival benefit.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-023-02704-8","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T10:03:02Z","timestamp":1679911382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of cholangitis on survival of patients with malignant biliary obstruction treated with percutaneous transhepatic biliary drainage"],"prefix":"10.1186","volume":"23","author":[{"given":"Jarmo","family":"Niemel\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raija","family":"Kallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Ohtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Saarnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Syrj\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"issue":"11","key":"2704_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371(11):1039\u201349. https:\/\/doi.org\/10.1056\/NEJMra1404198. PMID: 25207767.","journal-title":"N Engl J Med"},{"key":"2704_CR2","doi-asserted-by":"publisher","unstructured":"Valle JW. Advances in the treatment of metastatic or unresectable biliary tract cancer. Ann Oncol. 2010;21 Suppl 7:vii345 \u2013 348. PMID: 20943640. https:\/\/doi.org\/10.1093\/annonc\/mdq420.","DOI":"10.1093\/annonc\/mdq420"},{"key":"2704_CR3","doi-asserted-by":"publisher","unstructured":"Wagner AD, Syn NL, Moehler M, Grothe W, Yong WP, Tai BC, Ho J, Unverzagt S. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2017;8(8). PMID: 28850174. https:\/\/doi.org\/10.1002\/14651858.CD004064.pub4.","DOI":"10.1002\/14651858.CD004064.pub4"},{"issue":"6","key":"2704_CR4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2147\/tcrm.s3951","volume":"4","author":"T Walia","year":"2008","unstructured":"Walia T, Quevedo JF, Hobday TJ, Croghan G, Jatoi A. Colorectal cancer patients with liver metastases and severe hyperbilirubinemia: a consecutive series that explores the benefits and risks of chemotherapy. Ther Clin Risk Manag. 2008;4(6):1363\u20136. https:\/\/doi.org\/10.2147\/tcrm.s3951. PMID: 19337442.","journal-title":"Ther Clin Risk Manag"},{"key":"2704_CR5","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1007\/s00268-018-4567-0","volume":"42","author":"J Niemel\u00e4","year":"2018","unstructured":"Niemel\u00e4 J, Kallio R, Ohtonen P, Peral\u00e4 J, Saarnio J, Syrjal\u00e4 H. Is palliative percutaneous drainage for malignant biliary obstruction useful? World J Surg. 2018;42:2980\u20136. https:\/\/doi.org\/10.1007\/s00268-018-4567-0. PMID: 29536143.","journal-title":"World J Surg"},{"issue":"6","key":"2704_CR6","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/COC.0000000000000682","volume":"43","author":"DW Shin","year":"2020","unstructured":"Shin DW, Kim MJ, Lee JC, Kim J, Woo SM, Lee WJ, Lee KH, Hwang JH. Gemcitabine plus cisplatin chemotherapy prolongs the survival in advanced hilar cholangiocarcinoma: a large multicenter study. Am J Clin Oncol. 2020;43(6):422\u20137. https:\/\/doi.org\/10.1097\/COC.0000000000000682. PMID: 32118610.","journal-title":"Am J Clin Oncol"},{"key":"2704_CR7","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.21873\/anticanres.15079","volume":"41","author":"J Niemela","year":"2021","unstructured":"Niemela J, Syrjala H, Ohtonen P, Saarnio J, Kallio R. Chemotherapy improves survival after percutaneous biliary drainage in patients with pancreatic or biliary tract cancer with biliary obstruction. Anticancer Res. 2021;41:2979\u201384. https:\/\/doi.org\/10.21873\/anticanres.15079. PMID: 34083288.","journal-title":"Anticancer Res"},{"issue":"1","key":"2704_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/MCG.0000000000001512","volume":"56","author":"J Xie","year":"2022","unstructured":"Xie J, Garg S, Perisetti A, Tharian B, Murad MH, Inamdar S. Comparison of biliary drainage techniques for malignant biliary obstruction: a systematic review and network meta-analysis. J Clin Gastroenterol. 2022;56(1):88\u201397. https:\/\/doi.org\/10.1097\/MCG.0000000000001512. PMID: 33780212.","journal-title":"J Clin Gastroenterol"},{"key":"2704_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/gastroent13020020","volume":"13","author":"W Siu","year":"2022","unstructured":"Siu W, Tang RSY. The role of Cholangioscopy and EUS in the evaluation of indeterminate biliary strictures. Gastroenterol Insights. 2022;13:192\u2013205. https:\/\/doi.org\/10.3390\/gastroent13020020.","journal-title":"Gastroenterol Insights"},{"key":"2704_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/gastroent12040039","volume":"12","author":"T-T Chan","year":"2021","unstructured":"Chan T-T, Chew MCH, Tang RSY. Troubleshooting difficult bile Duct Access: Advanced ERCP Cannulation techniques, percutaneous biliary drainage, or EUS-Guided rendezvous technique? Gastroenterol. Insights. 2021;12:405\u201322. https:\/\/doi.org\/10.3390\/gastroent12040039.","journal-title":"Insights"},{"key":"2704_CR11","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1007\/s00330-011-2121-7","volume":"21","author":"CR Tapping","year":"2011","unstructured":"Tapping CR, Byass OR, Cast JE. Percutaneous transhepatic biliary drainage (PTBD) with or without stenting-complications, re-stent rate and a new risk stratification score. Eur Radiol. 2011;21:1948\u201355. https:\/\/doi.org\/10.1007\/s00330-011-2121-7. PMID: 21533867.","journal-title":"Eur Radiol"},{"key":"2704_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00270-011-0103-4","volume":"35","author":"R Uberoi","year":"2012","unstructured":"Uberoi R, Das N, Moss J, Robertson I. British Society of Interventional Radiology: biliary drainage and Stenting Registry (BDSR). Cardiovasc Intervent Radiol. 2012;35:127\u201338. https:\/\/doi.org\/10.1007\/s00270-011-0103-4. PMID: 21301847.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2704_CR13","doi-asserted-by":"publisher","unstructured":"Saluja SS, Gulati M, Garg PK, Pal H, Pal S, Sahni P, Chattopadhyay TK. Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol. 2008;6:944\u2013950.e3. PMID: 18585976. https:\/\/doi.org\/10.1016\/j.cgh.2008.03.028.","DOI":"10.1016\/j.cgh.2008.03.028"},{"key":"2704_CR14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.5152\/tjg.2019.18317","volume":"30","author":"QQ Zu","year":"2019","unstructured":"Zu QQ, Zhang JX, Wang B, Ye W, Liu S, Shi HB. Percutaneous transpapillary biliary stent placement for distal malignant biliary obstruction: outcomes and survival analysis. Turk J Gastroenterol. 2019;30:714\u201321. https:\/\/doi.org\/10.5152\/tjg.2019.18317. PMID: 31418416.","journal-title":"Turk J Gastroenterol"},{"issue":"4","key":"2704_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.tvir.2015.07.005","volume":"18","author":"CM Sutter","year":"2015","unstructured":"Sutter CM, Ryu RK. Percutaneous Management of malignant biliary obstruction. Tech Vasc Interv Radiol. 2015;18(4):218\u201326. https:\/\/doi.org\/10.1053\/j.tvir.2015.07.005. PMID: 26615162.","journal-title":"Tech Vasc Interv Radiol"},{"issue":"1","key":"2704_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00534-012-0561-3","volume":"20","author":"S Kiriyama","year":"2013","unstructured":"Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA, Gouma DJ, Garden OJ, Buchler MW, Yokoe M, Kimura Y, Tsuyuguchi T, Itoi T, Yoshida M, Miura F, Yamashita Y, Okamoto K, Gabata T, Hata J, Higuchi R, Windsor JA, Bornman PC, Fan ST, Singh H, de Santibanes E, Gomi H, Kusachi S, Murata A, Chen XP, Jagannath P, Lee S, Padbury R, Chen MF, Dervenis C, Chan AC, Supe AN, Liau KH, Kim MH, Kim SW, Tokyo Guidelines Revision Committee. TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2013;20(1):24\u201334. https:\/\/doi.org\/10.1007\/s00534-012-0561-3. PMID: 23307001.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2704_CR17","unstructured":"American Society of Anesthesiologists. ASA Physical Classification System. https:\/\/www.asahq.org\/resources\/clinical-information\/asa-physical-status-classification-system. Accessed 1 May 2021."},{"key":"2704_CR18","unstructured":"Eastern Cooperative Oncology Group. ECOG performance status. http:\/\/ecog-acrin.org\/resources\/ecog-performance-status. Accessed 1 May 2021."},{"key":"2704_CR19","unstructured":"Statistic Finland. https:\/\/www.stat.fi. Accessed 1 May 2021."},{"key":"2704_CR20","doi-asserted-by":"publisher","unstructured":"Textor J, van der Zander B, Gilthorpe MS, Liskiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package \u2018dagitty\u2019. Int J Epidemiol. 2016;45(6): 1887\u20131894, 2016. PMID: 28089956. https:\/\/doi.org\/10.1093\/ije\/dyw341.","DOI":"10.1093\/ije\/dyw341"},{"key":"2704_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00270-014-0992-0","volume":"38","author":"M Li","year":"2015","unstructured":"Li M, Bai M, Qi X, Li K, Yin Z, Wang J, Wu W, Zhen L, He C, Fan D, Zhang Z, Han G. Percutaneous transhepatic biliary metal stent for malignant hilar obstruction: results and predictive factors for efficacy in 159 patients from a single center. Cardiovasc Intervent Radiol. 2015;38:709\u201321. https:\/\/doi.org\/10.1007\/s00270-014-0992-0. PMID: 25338831.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2704_CR22","doi-asserted-by":"publisher","unstructured":"Sha J, Dong Y, Niu H. A prospective study of risk factors for in-hospital mortality in patients with malignant obstructive jaundice undergoing percutaneous biliary drainage. Medicine (Baltimore). 2019;98(15):e15131. PMID: 30985679. https:\/\/doi.org\/10.1097\/MD.0000000000015131.","DOI":"10.1097\/MD.0000000000015131"},{"issue":"6","key":"2704_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jhbp.458","volume":"24","author":"S Kiriyama","year":"2017","unstructured":"Kiriyama S, Takada T, Hwang TL, Akazawa K, Miura F, Gomi H, Mori R, Endo I, Itoi T, Yokoe M, Chen MF, Jan YY, Ker CG, Wang HP, Wada K, Yamaue H, Miyazaki M, Yamamoto M. Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis: an international multicenter observational study. J Hepatobiliary Pancreat Sci. 2017;24(6):329\u201337. https:\/\/doi.org\/10.1002\/jhbp.458. PMID: 28419764.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"2704_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13054-021-03480-1","volume":"25","author":"JR Lavillegrand","year":"2021","unstructured":"Lavillegrand JR, Mercier-Des-Rochettes E, Baron E, Pene F, Contou D, Favory R, Preau S, Galbois A, Molliere C, Miailhe AF, Reignier J, Monchi M, Pichereau C, Thietart S, Vieille T, Piton G, Preda G, Abdallah I, Camus M, Maury E, Guidet B, Dumas G, Ait-Oufella H. Acute cholangitis in intensive care units: clinical, biological, microbiological spectrum and risk factors for mortality: a multicenter study. Crit Care. 2021;25:49\u20131. https:\/\/doi.org\/10.1186\/s13054-021-03480-1. PMID: 33549136.","journal-title":"Crit Care"},{"key":"2704_CR25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s12029-013-9509-3","volume":"44","author":"M Crosara Teixeira","year":"2013","unstructured":"Crosara Teixeira M, Mak MP, Marques DF, Capareli F, Carnevale FC, Moreira AM, Ribeiro U Jr, Cecconello I, Hoff PM. Percutaneous transhepatic biliary drainage in patients with advanced solid malignancies: prognostic factors and clinical outcomes. J Gastrointest Cancer. 2013;44:398\u2013403. https:\/\/doi.org\/10.1007\/s12029-013-9509-3. PMID: 23760941.","journal-title":"J Gastrointest Cancer"},{"issue":"3","key":"2704_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.crad.2014.09.021","volume":"70","author":"JA Sutcliffe","year":"2015","unstructured":"Sutcliffe JA, Briggs JH, Little MW, McCarthy E, Wigham A, Bratby M, Tapping CR, Anthony S, Patel R, Phillips-Hughes J, Boardman P, Uberoi R. Antibiotics in interventional radiology. Clin Radiol. 2015;70(3):223\u201334. https:\/\/doi.org\/10.1016\/j.crad.2014.09.021. PMID: 25459674.","journal-title":"Clin Radiol"},{"issue":"8","key":"2704_CR27","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1007\/s00520-013-1796-5","volume":"21","author":"S Ahn","year":"2013","unstructured":"Ahn S, Lee YS, Lim KS, Lee JL. Malignant biliary obstructions: can we predict immediate postprocedural cholangitis after percutaneous biliary drainage? Support Care Cancer. 2013;21(8):2321\u20136. https:\/\/doi.org\/10.1007\/s00520-013-1796-5. PMID: 23529668.","journal-title":"Support Care Cancer"},{"issue":"2","key":"2704_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/SLA.0b013e31826f4b0e","volume":"257","author":"C Iacono","year":"2013","unstructured":"Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg. 2013;257(2):191\u2013204. https:\/\/doi.org\/10.1097\/SLA.0b013e31826f4b0e. PMID: 23013805.","journal-title":"Ann Surg"},{"key":"2704_CR29","doi-asserted-by":"publisher","unstructured":"Moole H, Dharmapuri S, Duvvuri A, Dharmapuri S, Boddireddy R, Moole V, Yedama P, Bondalapati N, Uppu A, Yerasi C. Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review. Can J Gastroenterol Hepatol. 2016;2016:4726078. PMID: 27648439. https:\/\/doi.org\/10.1155\/2016\/4726078.","DOI":"10.1155\/2016\/4726078"},{"key":"2704_CR30","doi-asserted-by":"crossref","unstructured":"Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology. 1991;101(5):1374 \u2013 1381. PMID: 1936809. https:\/\/doi.org\/0016-5085(91)90091-x.","DOI":"10.1016\/0016-5085(91)90091-X"},{"issue":"9","key":"2704_CR31","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/MCG.0000000000000275","volume":"49","author":"S Nennstiel","year":"2015","unstructured":"Nennstiel S, Weber A, Frick G, Haller B, Meining A, Schmid RM, Neu B. Drainage-related complications in percutaneous transhepatic biliary drainage: an analysis over 10 years. J Clin Gastroenterol. 2015;49(9):764\u201370. https:\/\/doi.org\/10.1097\/MCG.0000000000000275. PMID: 25518004.","journal-title":"J Clin Gastroenterol"},{"key":"2704_CR32","doi-asserted-by":"publisher","unstructured":"Kieler M, Unseld M, Bianconi D, Schindl M, Kornek GV, Scheithauer W, Prager GW. Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients. J Clin Med. 2020;9(3):648. PMID: 32121198. https:\/\/doi.org\/10.3390\/jcm9030648.","DOI":"10.3390\/jcm9030648"},{"key":"2704_CR33","doi-asserted-by":"publisher","unstructured":"Kasuga A, Ishii H, Ozaka M, Matsusaka S, Chin K, Mizunuma N, Yukisawa S, Matsueda K, Furuse J. Clinical outcome of biliary drainage for obstructive jaundice caused by colorectal and gastric cancers. Jpn J Clin Oncol. 2012;42:1167. PMID: 23072841. https:\/\/doi.org\/10.1093\/jjco\/hys168.","DOI":"10.1093\/jjco\/hys168"},{"key":"2704_CR34","doi-asserted-by":"publisher","unstructured":"Gwon DI, Ko GY, Sung KB, Yoon HK, Kim KA, Kim YJ, Kim TH, Lee WH. Clinical outcomes after percutaneous biliary interventions in patients with malignant biliary obstruction caused by metastatic gastric cancer. Acta Radiol. 2012;53:429. PMID: 22403081. https:\/\/doi.org\/10.1258\/ar.2012.110703.","DOI":"10.1258\/ar.2012.110703"},{"key":"2704_CR35","doi-asserted-by":"crossref","unstructured":"Kastelijn JB, van der Loos MA, Welsing PM, Dhondt E, Koopman M, Moons LM, Vleggaar FP. Clinical outcomes of biliary drainage of malignant biliary obstruction due to colorectal cancer metastases: A systematic review. Eur J Intern Med. 2021;88:81\u201388. PMID: 33931267. https:\/\/doi\/S0953-6205(21)00104-7.","DOI":"10.1016\/j.ejim.2021.03.032"},{"key":"2704_CR36","doi-asserted-by":"publisher","first-page":"e033576","DOI":"10.1136\/bmjopen-2019-033576","volume":"10","author":"J Rees","year":"2020","unstructured":"Rees J, Mytton J, Evison F, Mangat KS, Patel P, Trudgill N. The outcomes of biliary drainage by percutaneous transhepatic cholangiography for the palliation of malignant biliary obstruction in England between 2001 and 2014: a retrospective cohort study. BMJ Open. 2020;10:e033576\u2013033576. https:\/\/doi.org\/10.1136\/bmjopen-2019-033576. PMID 31980509.","journal-title":"BMJ Open"},{"key":"2704_CR37","doi-asserted-by":"crossref","unstructured":"Etminan M, Collins GS, Mansournia MA. Using Causal Diagrams to Improve the Design and Interpretation of Medical Research. Chest. 2020;158(1S): S21\u2013S28, 2020. PMID: 32658648. https:\/\/doi.org\/S0012-3692(20)30460-8.","DOI":"10.1016\/j.chest.2020.03.011"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02704-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-023-02704-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02704-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T10:05:49Z","timestamp":1679911549000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-023-02704-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1186\/s12876-023-02704-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"19 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by The Ethics Committee of Human Sciences of the University of Oulu. Informed consent was waived by The Ethics Committee of Human Sciences of University of Oulu because the study was register-based and does not require informed consent. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest. The authors had full control of all primary data and agree to allow the journal to review their data if requested.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}],"article-number":"91"}}